Provided is a method of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations suitable therefor.
本发明提供了一种利用一系列同时具有 5-HT1A 激动剂和 M1 肌松素活性的
异噁唑衍
生物治疗肠易激综合征(IBS)的方法,以及适用于该方法的制剂。